Phibro Animal Health Corporation is a global, diversified provider of animal health and mineral nutrition solutions that develops products and services for livestock health, nutrition and companion animal care across approximately 90 countries.

# Phibro Animal Health Corporation

## Overview
Phibro Animal Health Corporation is a global, diversified provider of animal health and mineral nutrition solutions. The company develops products and services for livestock health, nutrition, and companion animal care.

## Global footprint and customers
- Product lines: approximately 790 product lines  
- Geographic reach: approximately 90 countries  
- Customer base: approximately 4,800 customers

## Product portfolio
- Animal health products: antibacterials, anticoccidials, nutritional specialty products, vaccines and vaccine adjuvants  
- Processing aids: antibacterials and other processing aids used in the ethanol fermentation industry  
- Mineral nutrition products: formulations to fortify diets and support optimal health  
- Companion animal: ongoing investment to develop products for companion animals  
- Additional offerings: ingredients for personal care, industrial chemical, and chemical catalyst industries; performance products sold directly to customers in these industries

## Markets, channels, and growth focus
- Sales channels: direct sales to integrated poultry, cattle, and swine producers; sales through animal feed manufacturers, wholesalers, distributors, and veterinarians  
- Regional emphasis: North America, Latin America, Asia Pacific, Europe, Africa, and the Middle East  
- Growth strategy: rely on an established network of sales, marketing, and distribution professionals and direct resources toward expanding the companion animal segment

## Corporate and stock information
- Legal structure: Delaware corporation  
- Stock: Class A common stock trades on Nasdaq under the symbol PAHC; Class B common stock is not listed or traded  
- Terminology: references to “we,” “our,” “Company,” “Phibro,” and “PAHC” refer to Phibro Animal Health Corporation and its subsidiaries

Phibro Animal Health Corporation is a global leader in animal health, mineral nutrition, and performance products, dedicated to improving the health of food and companion animals.

# Phibro Animal Health Corporation

## Business description

Phibro Animal Health Corporation supplies products and services for animal health, mineral nutrition, and specialty performance ingredients. The company serves livestock producers, farmers, veterinarians, and consumers with solutions for disease prevention, control, and treatment, as well as nutritional support for food and companion animals.

Primary areas of operation:
- Animal Health: development, manufacturing, and marketing of products for disease prevention, control, and treatment.
- Mineral Nutrition: trace minerals and formulations to fortify animal diets.
- Performance Products: specialty ingredients for personal care, industrial chemicals, and chemical catalysts.

## Key products

Phibro markets about 750 product lines across species and segments, including:

- Animal Health
  - Antibacterials (e.g., Stafac®)
  - Anticoccidials (e.g., Nicarb®, Aviax®)
  - Nutritional specialty products (e.g., OmniGen®)
  - Vaccines for poultry, swine, cattle, and aquaculture
- Mineral Nutrition
  - Trace minerals (e.g., zinc, copper, manganese)
  - Specialized formulations for various animal species

## Operations and distribution

- Serves approximately 4,200 customers in over 80 countries
- Employs around 1,940 people in 53 locations across 32 countries
- Sells through direct channels to livestock producers and through distribution partnerships with animal feed manufacturers, wholesalers, and veterinarians

## Financial performance (fiscal year ended June 30, 2024)

- Total Net Sales: $1.018 billion
  - Animal Health: $706 million
  - Mineral Nutrition: $244 million
  - Performance Products: $68 million
- Adjusted EBITDA: $111 million
- Net Income: $18 million

## Growth focus

Phibro is expanding its presence in the companion animal sector while maintaining its position in livestock markets. The company is investing in product development and building its sales and marketing networks across global markets.

## Stock information

- Publicly traded on Nasdaq under the ticker PAHC
- Two classes of stock: Class A (publicly traded) and Class B (not listed)

PHIBRO ANIMAL HEALTH CORP

10-K / August 26, 2026

10-K / August 28, 2024

10-K / August 26, 2026

Phibro Animal Health Corporation

Overview

Global footprint and customers

Product portfolio

Markets, channels, and growth focus

Corporate and stock information